Tradestie Institutional Equity Comparison Engine
BOLD vs JNJ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
JNJ Overall Edge
JNJ Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Johnson & Johnson (JNJ) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus JNJ at 23.3x Forward P/E and 26.6% operating margin (+5.9% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against JNJ sits in CONSOLIDATION (45th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
JNJ
BOLD N/M vs JNJ 23.3x Fwd P/E
Growth & Margin Winner
JNJ
Op Margin 0.0% vs 26.6% ยท YoY +0.0% vs +5.9%
Momentum & Technical Winner
JNJ
1Y +101.7% vs +33.6% ยท 52W Pos 62% vs 78%
Options & Structure Winner
JNJ
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (45th %ile IV)
BOLD
NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap
$56.2M
1M Return
-4.92%
1Y Return
+101.74%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 25.0
Fund 50.0
Flow 50.0
Mom 60.0
JNJ
NYSE
Johnson & Johnson
Pharmaceutical Preparations
$270.47
+1.25% 1D
Market Cap
$643.1B
1M Return
+1.07%
1Y Return
+33.56%
Forward P/E
23.3x
Unified AI Score
57.8 / 100
HOLD
Tech 47.0
Fund 54.0
Flow 66.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BOLD +101.74%
JNJ +33.56%
Spread: +68.18 pp (BOLD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BOLD TTM Op. Margin: 0.0%
JNJ TTM Op. Margin: 26.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOLD vs JNJ. Trailing 12-month operating profitability (BOLD 0.0% vs JNJ 26.6%) and valuation multiples (BOLD N/M vs JNJ 23.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BOLD | JNJ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $56.2M | $643.1B | Larger Scale | JNJ |
| Trailing P/E Ratio Valuation | N/M | 40.5x | Lower Multiple | JNJ |
| Forward P/E Ratio Valuation | N/M | 23.3x | Lower Multiple | JNJ |
| Revenue Growth (YoY) Growth | +0.0% | +5.9% | Higher Growth | JNJ |
| Operating Margin (TTM) Profitability | 0.0% | 26.6% | Higher Margin | JNJ |
| Net Profit Margin Profitability | 0.0% | 16.2% | Higher Margin | JNJ |
| Return on Equity (ROE) Capital Efficiency | -64.6% | 20.0% | Higher ROE | JNJ |
| 52-Week Range Position Momentum | 62% ($1โ$3) | 78% ($199โ$290) | Stronger Trend | JNJ |
| Beta / 30D Volatility Risk Regime | -0.08ฮฒ ยท 28% Vol | -0.04ฮฒ ยท 25% Vol | Lower Realized Risk | JNJ |
| Unified Institutional Score Composite Signal | 36.8 / 100 (SELL) | 57.8 / 100 (HOLD) | Higher Composite | JNJ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BOLD vs JNJ Buy Guide
BOLD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
JNJ
CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
45th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BOLD nor JNJ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.